BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Soota K, Maliakkal B. Ribavirin induced hemolysis: A novel mechanism of action against chronic hepatitis C virus infection. World J Gastroenterol 2014; 20(43): 16184-16190 [PMID: 25473172 DOI: 10.3748/wjg.v20.i43.16184]
URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16184.htm
Number Citing Articles
1
N. M. Faustova, A. E. Saloponova, M. V. Miroshnikov, M. N. Makarova, V. G. Makarov. Assessment of functional safety of blood forming organs in research of toxicological properties of medicinal products (Review). Part 1. Features of the hematopoietic organs of laboratory animals. Mechanisms of hematotoxicityRegulatory Research and Medicine Evaluation 2025; 15(3) doi: 10.30895/1991-2919-2025-15-3-278-288
2
Maryam Ebrahimi, Fatemeh Dodangeh, Mahsa Javan, Mohammad Doroudian, Mobina Moradi. Curcumin-based nanomaterials for dual-target inhibition of SARS-CoV-2 omicron main protease and HMPV RNA polymerase: A computational studyInternational Journal of Biological Macromolecules 2026;  doi: 10.1016/j.ijbiomac.2026.152984
3
Sherry C. Wen, John V. Williams, C. J. Papasian. New Approaches for Immunization and Therapy against Human MetapneumovirusClinical and Vaccine Immunology 2015; 22(8) doi: 10.1128/CVI.00230-15
4
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patientsNefrología (English Edition) 2017; 37(2) doi: 10.1016/j.nefroe.2017.04.010
5
Chun‐Jen Liu. Simple predictor for anemia in chronic hepatitis C patients receiving peginterferon plus ribavirinAdvances in Digestive Medicine 2016; 3(1) doi: 10.1016/j.aidm.2016.01.001
6
Ming-Ling Chang, Jing-Hong Hu, Ching-Hao Yen, Kuan-Hsing Chen, Chia-Jung Kuo, Ming-Shyan Lin, Cheng-Han Lee, Shiang-Chi Chen, Rong-Nan Chien. Evolution of ferritin levels in hepatitis C patients treated with antiviralsScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-76871-z
7
Md Mohosin Rana. Polymer-based nano-therapies to combat COVID-19 related respiratory injury: progress, prospects, and challengesJournal of Biomaterials Science, Polymer Edition 2021; 32(9) doi: 10.1080/09205063.2021.1909412
8
Javier Ampuero, Manuel Romero-Gómez. Pharmacogenetics of Ribavirin-Induced Anemia in Hepatitis CPharmacogenomics 2016; 17(14) doi: 10.2217/pgs.16.28
9
Fernanda Bellini Lunardi MICHELS, Ana Cristina de Castro AMARAL, Roberto José de CARVALHO-FILHO, Gustavo de Almeida VIEIRA, Ana Lucia da Silva SOUZA, Maria Lucia Gomes FERRAZ. HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIRArquivos de Gastroenterologia 2020; 57(1) doi: 10.1590/s0004-2803.202000000-09
10
Kristina Baktikulova, Saulesh Kurmangaliyeva, Zamza Khairullina, Kairat Kurmangaliyev, Konstantin Tissin. Role of Erythrocyte Phosphatidylserine Externalization in Anemia among Patients with Hepatitis B Virus- and Hepatitis C Virus-related CirrhosisWest Kazakhstan Medical Journal 2026; 67(5) doi: 10.4103/wkmj.wkmj_26_26
11
Saleh A. Alqahtani, Mark S. Sulkowski. HCV: The Journey from Discovery to a CureTopics in Medicinal Chemistry 2019; 31 doi: 10.1007/7355_2018_59
12
Yasmin Abo-zeid, Gareth R. Williams, Lila Touabi, Gary R. McLean. An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticlesInternational Journal of Pharmaceutics 2020; 589 doi: 10.1016/j.ijpharm.2020.119826
13
Zhidkova Ekaterina, Stepanycheva Daria, Grebenkina Lyubov, Mikhina Ekaterina, Maksimova Varvara, Grigoreva Diana, Matveev Andrey, Lesovaya Ekaterina. Synthetic 1,2,4-triazole-3-carboxamides Induce Cell Cycle Arrest and Apoptosis in Leukemia CellsCurrent Pharmaceutical Design 2023; 29(43) doi: 10.2174/0113816128275084231202153602
14
Ramakrishna Behara, Nancy Reau. Updates on hepatitis C virus therapy in the direct-acting antiviral eraCurrent Opinion in Gastroenterology 2017; 33(3) doi: 10.1097/MOG.0000000000000350
15
Fateme Mozaffari, Setayesh Fakhari, Ameneh Elikaei, Zahra Ahmadi, Behrokh Farahmand, Ali Maleki. Divergent origins, divergent pandemic potential: A comparative analysis of HMPV and SARS-CoV-2Journal of Clinical Virology Plus 2025; 5(3) doi: 10.1016/j.jcvp.2025.100223
16
Brant L. Kedrowski, William F. Wacholtz. NMR Spectroscopy in the Undergraduate Curriculum: Upper-Level Courses and Across the Curriculum Volume 3ACS Symposium Series 2016; 1225 doi: 10.1021/bk-2016-1225.ch002
17
Chinyere Aloke, Nwogo Ajuka Obasi, Patrick Maduabuchi Aja, Chinedum Uche Emelike, Chinedu Ogbonnia Egwu, Olamide Jeje, Chuks Oswald Edeogu, Olalekan Olugbenga Onisuru, Obasi Uche Orji, Ikechukwu Achilonu. Combating Lassa Fever in West African Sub-Region: Progress, Challenges, and Future PerspectivesViruses 2023; 15(1) doi: 10.3390/v15010146
18
Az Alddien Natfji, Helen M.I. Osborn, Francesca Greco. Feasibility of polymer-drug conjugates for non-cancer applicationsCurrent Opinion in Colloid & Interface Science 2017; 31 doi: 10.1016/j.cocis.2017.07.004
19
Soraya Abad, Almudena Vega, Eduardo Hernández, Evangelina Mérida, Patricia de Sequera, Marta Albalate, Nicolás Macías, Monica Milla, Juan M. López-Gómez. Universal Sustained Viral Response to the Combination of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with/without Ribavirin in Patients on Hemodialysis Infected with Hepatitis C Virus Genotypes 1 and 4American Journal of Nephrology 2017; 45(3) doi: 10.1159/000454819
20
Bettina Leber, Irina Balázs, Angela Horvath, Andreas Posch, Andrea Streit, Walter Spindelböck, Nicole Feldbacher, Philipp Stiegler, Rudolf E. Stauber, Gerald N. Rechberger, Manfred Kollroser, Wolfgang Sattler, Christoph Nusshold, Vanessa Stadlbauer. Direct acting antiviral therapy rescues neutrophil dysfunction and reduces hemolysis in hepatitis C infectionTranslational Research 2021; 232 doi: 10.1016/j.trsl.2020.12.005
21
Frederick Hansen, Michael A. Jarvis, Heinz Feldmann, Kyle Rosenke. Lassa Virus Treatment OptionsMicroorganisms 2021; 9(4) doi: 10.3390/microorganisms9040772
22
Carlos Guerrero‐Sanchez, Roberto Yañez‐Macias, Miguel Rosales‐Guzmán, Marco A. De Jesus‐Tellez, Claudia Piñon‐Balderrama, Joris J. Haven, Graeme Moad, Tanja Junkers, Ulrich S. Schubert. RAFT Polymerization2021;  doi: 10.1002/9783527821358.ch23
23
Shailendra K. Saxena, Jitesh Yadav, Hari Kishan, Arpita S. Harnam, Swatantra Kumar, Vimal K. Maurya, Saniya Ansari, Janusz T. Paweska, Radha Kanta Ratho. Pathogenesis and current advancement in treatment and prevention strategies for Human metapneumovirusVirology 2026; 617 doi: 10.1016/j.virol.2026.110798
24
Soraya Abad, Almudena Vega, Diego Rincón, Eduardo Hernández, Evangelina Mérida, Nicolás Macías, Raquel Muñoz, Mónica Milla, Jose Luño, Juan Manuel López-Gómez. Eficacia de los antivirales de acción directa en la infección por el virus de la hepatitis C en pacientes en hemodiálisisNefrología 2017; 37(2) doi: 10.1016/j.nefro.2016.10.003
25
Aarthi Surendran, Aditya Bhalla, Martin Brunel Whyte. Improved diabetes control, allowing insulin cessation, after direct acting antiviral treatment (DAAT) of hepatitis CBMJ Case Reports 2022; 15(4) doi: 10.1136/bcr-2021-243491
26
Chao-Ming Shih, Chih-Hsien Wu, Wen-Jun Wu, Yi-Min Hsiao, Jiunn-Liang Ko. Hypericin inhibits hepatitis C virus replication via deacetylation and down-regulation of heme oxygenase-1Phytomedicine 2018; 46 doi: 10.1016/j.phymed.2017.08.009
27
S.T.R. Moolamalla, Rami Balasubramanian, Ruchi Chauhan, U. Deva Priyakumar, P.K. Vinod. Host metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approachMicrobial Pathogenesis 2021; 158 doi: 10.1016/j.micpath.2021.105114
28
Yuan-yuan Ma, Mu-qing Yang, Zhi-gang He, Qing Wei, Ji-yu Li. Biology of Myelomonocytic Cells2017;  doi: 10.5772/67673
29
Muhammad Jahangir Hossen, Md. Abdul Matin, Mahmudul Hasan Sikder, Md. Selim Ahmed, Moizur Rahman. Recent Advancements in Microbial Diversity2022;  doi: 10.1016/B978-0-12-822368-0.00016-5